Abstract:Background: Ulcerative colitis (UC) is a type of chronic inflammatory bowel disease (IBD) closely associated with intestinal homeostasis dysregulation. At present, clinical treatment options for UC are highly limited. Interleukin-22 (IL-22) treatment is regarded as an effective therapeutic strategy for the treatment of UC. The abnormal expression of long noncoding RNAs (lncRNAs) has been detected in many inflammatory diseases, including UC. In this study, we aimed to investigate the function of IL-22 and the function of lncRNAs in the UC on dextran sulfate sodium (DSS)-induced colitis in mice. Methods: The mice were intraperitoneally injected with IL-22 or PBS and then DSS was used to induce colitis. The histopathological parameters of the mice were determined using histological and molecular detection approaches. Then, RNA-sequencing was performed to screen the differential lncRNAs expression profile compared with the control group, before and after IL-22 treatment of the mice. Quantitative real time PCR (qRT-PCR) and lentivirus identified lncRNA-Ulcerative Colitis LncRNA (lncRNA-UCL) as the molecular regulator of the colitis mice. RNA-pulldown was performed to validate the interaction between lncRNA-UCL and mmu-miR-568. Meanwhile, claudin-1 was predicted and confirmed as the target molecule of mmu-miR-568 using dual luciferase assay. Findings: IL-22 treatment could significantly improve the histopathological features and decrease pro-inflammatory cytokine production in DSS-induced colitis mice by enhancing the expressions of tight and adherent junction proteins, and promoting the proliferation and suppressing the apoptosis of intestinal epithelial cells. LncRNA-UCL expression was significantly downregulated in DSS-induced colitis mice, while IL-22 treatment effectively reversed this effect. In terms of mechanism, lncRNA-UCL regulates intestinal epithelial homeostasis by sequestering mmu-miR-568 and maintaining the expression of the tight junction protein, claudin-1. Interpretation: Our results implied that IL-22 can alleviate symptoms of DSS-induced colitis via enhancing lncRNA-UCL expression by maintaining the expression levels of tight junction and adherent junction proteins. Therefore, the lncRNA/miR-568/claudin-1 axis plays a pivotal role in regulating intestinal epithelial cell homeostasis under the effect of IL-22.Funding: This study was supported by the National Natural Science Foundation of China (No.81800489). We are grateful to the collaboration of all fellows at Department ofGastroenterology, Shenzhen People’s Hospital, Jinan University.Declaration of Interest: The authors have declared that no competing interest exists.Ethical Approval: All experiments performed on animals were approved by the Medical EthicsCommittee of Shenzhen People’s Hospital, Shenzhen, China.

607 Functional Characterization and Regulation of Claudin-8: A Novel Regulator of Colonic Epithelial Barrier Function in Inflammatory Bowel Disease

Pro-inflammatory Mir-223 Mediates the Cross-Talk Between the IL23 Pathway and the Intestinal Barrier in Inflammatory Bowel Disease

Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis

Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the Mir21-Cldn8 Pathway

IL-21 mediates microRNA-423-5p /claudin-5 signal pathway and intestinal barrier function in inflammatory bowel disease

IDDF2018-ABS-0193 Cytokine IL9 mediates the pathogenesis of crohn’s disease through the MIR21-CLDN8 pathway

Epithelial CRL4 DCAF2 is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells

Epithelial CRL4 DCAF2 is critical for maintaining intestinal homeostasis by regulating the proliferation and repair of intestinal epithelial cells

INFLAMMATION-TRIGGERED CLAUDIN-23 DOWNREGULATION IMPACTS INTESTINAL EPITHELIAL BARRIER FUNCTION

Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer

Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity

Intestinal Claudin-7 deficiency impacts the intestinal microbiota in mice with colitis

Fbxw7 Increases CCL2/7 in CX3CR1(hi) Macrophages to Promote Intestinal Inflammation

Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model

Epithelial CRL4DCAF2 Is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells

ClC-3 Chloride Channel/antiporter Defect Contributes to Inflammatory Bowel Disease in Humans and Mice

Claudins regulate the intestinal barrier in response to immune mediators

Il-22 Ameliorates Dss-Induced Colitis Through the Upregulation of LncRNA-UCL to Accelerate Claudin-1 Expression via Sequestering miR-568 in Mice

Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling

Intestinal epithelial Cldn-7 regulates intestinal inflammation by altering the gut microbiota

Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7